SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Perry Maxwell, Florinda Melendez-Rodríguez, Kyle B. Matchett, Julian Aragones, Nathalie Ben-Califa, Heidelinde Jaekel, Ludger Hengst, Herbert Lindner, Andre Bernardini, Ulf Brockmeier, Joachim Fandrey, Fritz Grunert, Howard S. Oster, Moshe Mittelman, Mohamed El-Tanani, Markus Thiersch, Edith M. Schneider Gasser, Max Gassmann, David Dangoor, Robert J. Cuthbert, Alexandra Irvine, Anne Jordan, Terence Lappin, John Thompson, Drorit Neumann, Novel antibodies directed against the human erythropoietin receptor: creating a basis for clinical implementation, British Journal of Haematology, 2015, 168, 3
  2. 2
    Britt Christensen, Birgitte Nellemann, Kasper Thorsen, Morten Muhlig Nielsen, Steen B. Pedersen, Marie Juul Ornstrup, Jens Otto L. JØrgensen, Niels Jessen, Prolonged erythropoietin treatment does not impact gene expression in human skeletal muscle, Muscle & Nerve, 2015, 51, 4
  3. 3
    Federico Moriconi, Pierluigi Ramadori, Frank C. Schultze, Martina Blaschke, Ahmad Amanzada, Sajjad Khan, Giuliano Ramadori, Characterization of the erythropoietin/erythropoietin receptor axis in a rat model of liver damage and cholangiocarcinoma development, Histochemistry and Cell Biology, 2013, 139, 3, 473

    CrossRef

  4. 4
    M Aapro, W Jelkmann, S N Constantinescu, B Leyland-Jones, Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer, British Journal of Cancer, 2012, 106, 7, 1249

    CrossRef

  5. 5
    S. Elliott, L. Busse, S. Swift, I. McCaffery, J. Rossi, P. Kassner, C. G. Begley, Lack of expression and function of erythropoietin receptors in the kidney, Nephrology Dialysis Transplantation, 2012, 27, 7, 2733

    CrossRef

  6. 6
    Tania V. Lopez, Terence R.J. Lappin, Perry Maxwell, Zhanzhong Shi, Rebeca Lopez-Marure, Cecilia Aguilar, Leticia Rocha-Zavaleta, Autocrine/paracrine erythropoietin signalling promotes JAK/STAT-dependent proliferation of human cervical cancer cells, International Journal of Cancer, 2011, 129, 11
  7. 7
    Rui Li, Lingyan Yuan, Jin Wang, Jiejun Wang, Co-expression of erythropoietin receptor with human epidermal growth factor 2 may counteract trastuzumab inhibition in gastric cancer, Medical Hypotheses, 2011, 77, 6, 948

    CrossRef

  8. 8
    Matthew McKinney, Murat O. Arcasoy, Erythropoietin for oncology supportive care, Experimental Cell Research, 2011, 317, 9, 1246

    CrossRef

  9. You have free access to this content9
    Wolfgang Jelkmann, Biosimilar epoetins and other “follow-on” biologics: Update on the European experiences, American Journal of Hematology, 2010, 85, 10
  10. 10
    Zoltán Kiss, Steven Elliott, Kinga Jedynasty, Vladimír Tesar, János Szegedi, Discovery and basic pharmacology of erythropoiesis-stimulating agents (ESAs), including the hyperglycosylated ESA, darbepoetin alfa: an update of the rationale and clinical impact, European Journal of Clinical Pharmacology, 2010, 66, 4, 331

    CrossRef

  11. 11
    Lisa Barbera, Gillian Thomas, Erythropoiesis stimulating agents, thrombosis and cancer, Radiotherapy and Oncology, 2010, 95, 3, 269

    CrossRef

  12. 12
    J Glaspy, J Crawford, J Vansteenkiste, D Henry, S Rao, P Bowers, J A Berlin, D Tomita, K Bridges, H Ludwig, Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes, British Journal of Cancer, 2010, 102, 2, 301

    CrossRef

  13. 13
    Steve Elliott, Leigh Busse, Ian McCaffery, John Rossi, Angus Sinclair, Chris Spahr, Susan Swift, C. Glenn Begley, Identification of a sensitive anti-erythropoietin receptor monoclonal antibody allows detection of low levels of EpoR in cells, Journal of Immunological Methods, 2010, 352, 1-2, 126

    CrossRef

  14. 14
    Alireza Mirmohammadsadegh, Alessandra Marini, Annett Gustrau, Dana Delia, Sandeep Nambiar, Mohamed Hassan, Ulrich R Hengge, Role of Erythropoietin Receptor Expression in Malignant Melanoma, Journal of Investigative Dermatology, 2010, 130, 1, 201

    CrossRef

  15. 15
    Jolanta Szenajch, Gabriel Wcislo, Jee-Yeong Jeong, Cezary Szczylik, Laurie Feldman, The role of erythropoietin and its receptor in growth, survival and therapeutic response of human tumor cells, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2010, 1806, 1, 82

    CrossRef

  16. 16
    Perrine Marec-Berard, Pascal Chastagner, Diana Kassab-Chahmi, Nicole Casadevall, Christian Marchal, Jean-Louis Misset, Isabelle Ray-Coquard, 2007 Standards, Options, and Recommendations: Use of erythropoiesis-stimulating agents (ESA: epoetin alfa, epoetin beta, and darbepoetin) for the management of anemia in children with cancer, Pediatric Blood & Cancer, 2009, 53, 1
  17. 17
    Francesca Merchionne, Franco Dammacco, Biological functions and therapeutic use of erythropoiesis-stimulating agents: perplexities and perspectives, British Journal of Haematology, 2009, 146, 2
  18. 18
    Domenico Ribatti, Erythropoietin and cancer, a double-edged sword, Leukemia Research, 2009, 33, 1, 1

    CrossRef

  19. 19
    John A. Glaspy, Erythropoietin in Cancer Patients, Annual Review of Medicine, 2009, 60, 1, 181

    CrossRef

  20. 20
    David P Steensma, A premature obituary for erythropoietin analogues, The Lancet Oncology, 2008, 9, 4, 316

    CrossRef

  21. 21
    Olivier Negre, Floriane Fusil, Annie Henri, Jean-Marie Villette, Philippe Leboulch, Yves Beuzard, Emmanuel Payen, Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin, Experimental Hematology, 2008, 36, 4, 412

    CrossRef

  22. 22
    Dominique Spaëth, Epoetin beta once weekly: review of its efficacy and safety in patients with chemotherapy-induced anemia, Expert Review of Anticancer Therapy, 2008, 8, 6, 875

    CrossRef

  23. 23
    John Glaspy, Erythropoiesis-Stimulating Agents and the Practice of Gynecologic Oncology, Clinical Ovarian Cancer, 2008, 1, 1, 44

    CrossRef

  24. 24
    A M Sinclair, N Rogers, L Busse, I Archibeque, W Brown, P D Kassner, J E V Watson, G E Arnold, K C Q Nguyen, S Powers, S Elliott, Erythropoietin receptor transcription is neither elevated nor predictive of surface expression in human tumour cells, British Journal of Cancer, 2008, 98, 6, 1059

    CrossRef

  25. 25
    K Nayan S Rao, Azan S Binbrek, Burton E Sobel, Heart disease and erythropoietin, Future Cardiology, 2008, 4, 1, 57

    CrossRef

  26. 26
    Magdalena Laugsch, Eric Metzen, Tanja Svensson, Reinhard Depping, Wolfgang Jelkmann, Lack of functional erythropoietin receptors of cancer cell lines, International Journal of Cancer, 2008, 122, 5
  27. 27
    P. Borrione, A. Mastrone, R. A. Salvo, A. Spaccamiglio, L. Grasso, A. Angeli, Oxygen delivery enhancers: Past, present, and future, Journal of Endocrinological Investigation, 2008, 31, 2, 185

    CrossRef

  28. 28
    Wolfgang Jelkmann, Julia Bohlius, Michael Hallek, Arthur J. Sytkowski, The erythropoietin receptor in normal and cancer tissues, Critical Reviews in Oncology/Hematology, 2008, 67, 1, 39

    CrossRef

  29. 29
    Tiffany M. Phillips, Kwanghee Kim, Erina Vlashi, William H. McBride, Frank Pajonk, Effects of Recombinant Erythropoietin on Breast Cancer-Initiating Cells, Neoplasia, 2007, 9, 12, 1122

    CrossRef

  30. 30
    C. Anthony Blau, Erythropoietin in Cancer: Presumption of Innocence?, STEM CELLS, 2007, 25, 8
  31. 31
    Jane Ahlqvist-Rastad, Maria Albertsson, Jonas Bergh, Gunnar Birgegård, Peter Johansson, Bertil Jonsson, Elisabeth Kjellen, Sven Påhlman, Björn Zackrisson, Anders Österborg, Erythropoietin therapy and cancer related anaemia: updated Swedish recommendations, Medical Oncology, 2007, 24, 3, 267

    CrossRef

  32. 32
    Angus M. Sinclair, Marque D. Todd, Kevin Forsythe, Susan J. Knox, Steve Elliott, C. Glenn Begley, Expression and function of erythropoietin receptors in tumors, Cancer, 2007, 110, 3
  33. 33
    Vivien M. Hodges, Susan Rainey, Terence R. Lappin, A. Peter Maxwell, Pathophysiology of anemia and erythrocytosis, Critical Reviews in Oncology/Hematology, 2007, 64, 2, 139

    CrossRef

  34. 34
    Roland H. Wenger, Armin Kurtz, Erythropoietin, Comprehensive Physiology,